SOW
NAMS icon

State of Wyoming’s NewAmsterdam Pharma NAMS Stock Holding History

State of Wyoming’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17K Sell
532
-69
-11% -$2.25K ﹤0.01% 1687
2025
Q4 		$21.1K Buy
601
+21
+4% +$764 ﹤0.01% 1689
2025
Q3 		$16.5K Buy
580
+30
+5% +$719 ﹤0.01% 1721
2025
Q2 		$9.96K Buy
+550
New +$10K ﹤0.01% 1763

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

State of Wyoming's NAMS Position: Q1 2026 in Review

State of Wyoming reduced its NewAmsterdam Pharma (NAMS) stake by 11% in Q1 2026, selling an estimated $2.25K and leaving 532 shares worth $17K. The position accounts for ﹤0.01% of the portfolio, ranked #1687.

State of Wyoming first reported a position in NAMS in Q2 2025 and has held it in 4 quarters since. The position peaked at $21.1K in Q4 2025. 170 funds tracked by Wall St. Rank hold NAMS as of Q1 2026.

  • State of Wyoming held 532 shares of NewAmsterdam Pharma worth $17K as of Q1 2026.
  • State of Wyoming sold 69 NewAmsterdam Pharma shares in Q1 2026, an estimated $2.25K.
  • NewAmsterdam Pharma made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1687 holding.
  • State of Wyoming first reported a position in NewAmsterdam Pharma in Q2 2025 and has held it in 4 quarters since.
  • State of Wyoming's NewAmsterdam Pharma position peaked at $21.1K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.